These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27109490)

  • 41. Antiangiogenesis: new frontiers in therapeutic development.
    LaMontagne KR
    Angiogenesis; 2005; 8(4):285-7. PubMed ID: 16400519
    [No Abstract]   [Full Text] [Related]  

  • 42. Biomarkers of response to angiogenesis inhibitors: an open and unsolved question.
    Ribatti D
    Eur J Cancer; 2010 Jan; 46(1):6-8. PubMed ID: 19926474
    [No Abstract]   [Full Text] [Related]  

  • 43. Nanotechnology for antiangiogenic cancer therapy.
    Kobayashi H; Lin PC
    Nanomedicine (Lond); 2006 Jun; 1(1):17-22. PubMed ID: 17716205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current status of antiangiogenic factors.
    Talks KL; Harris AL
    Br J Haematol; 2000 Jun; 109(3):477-89. PubMed ID: 10886192
    [No Abstract]   [Full Text] [Related]  

  • 45. Antiangiogenic Effect of Flavonoids and Chalcones: An Update.
    Mirossay L; Varinská L; Mojžiš J
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29271940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Angiogenic mechanisms in cancer].
    Bjerkvig R
    Tidsskr Nor Laegeforen; 2000 Nov; 120(29):3501. PubMed ID: 11188372
    [No Abstract]   [Full Text] [Related]  

  • 47. Antiangiogenic effects of zoledronate on cancer neovasculature.
    Metcalf S; Pandha HS; Morgan R
    Future Oncol; 2011 Nov; 7(11):1325-33. PubMed ID: 22044205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endostatin: are the 2 years up yet?
    Schellens JH; Ratain MJ
    J Clin Oncol; 2002 Sep; 20(18):3758-60. PubMed ID: 12228194
    [No Abstract]   [Full Text] [Related]  

  • 49. Combating angiogenesis early: potential of targeting tumor-recruited neutrophils in cancer therapy.
    Quigley JP; Deryugina EI
    Future Oncol; 2012 Jan; 8(1):5-8. PubMed ID: 22149028
    [No Abstract]   [Full Text] [Related]  

  • 50. Angiogenesis. A boost for tumor starvation.
    Marx J
    Science; 2003 Jul; 301(5632):452-4. PubMed ID: 12881543
    [No Abstract]   [Full Text] [Related]  

  • 51. Antiangiogenic therapy: a universal chemosensitization strategy for cancer?
    Kerbel RS
    Science; 2006 May; 312(5777):1171-5. PubMed ID: 16728631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNAs: promising new antiangiogenic targets in cancer.
    Gallach S; Calabuig-Fariñas S; Jantus-Lewintre E; Camps C
    Biomed Res Int; 2014; 2014():878450. PubMed ID: 25197665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Written in the blood.
    Lewis R
    Nature; 2006 Mar; 440(7084):710-1. PubMed ID: 16637100
    [No Abstract]   [Full Text] [Related]  

  • 54. Cellular and soluble markers of tumor angiogenesis: from patient selection to the identification of the most appropriate postresistance therapy.
    Bertolini F; Marighetti P; Shaked Y
    Biochim Biophys Acta; 2010 Dec; 1806(2):131-7. PubMed ID: 20685298
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synopsis of angiogenesis inhibitors in oncology.
    Ellis LM; Liu W; Fan F; Jung YD; Reinmuth N; Stoeltzing O; Takeda A; Akagi M; Parikh AA; Ahmad S
    Oncology (Williston Park); 2002 May; 16(5 Suppl 4):14-22. PubMed ID: 12102576
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiogenesis and vascular targeting in Ewing sarcoma: a review of preclinical and clinical data.
    DuBois SG; Marina N; Glade-Bender J
    Cancer; 2010 Feb; 116(3):749-57. PubMed ID: 20029966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Inhibition of angiogenesis by proteins, peptides and "small molecules"].
    Jayson G; Armand JP; Berdel WE
    Onkologie; 2005 Oct; 28 Suppl 4():29-34. PubMed ID: 16205103
    [No Abstract]   [Full Text] [Related]  

  • 58. Escape mechanisms after antiangiogenic treatment, or why are the tumors growing again?
    Hlushchuk R; Makanya AN; Djonov V
    Int J Dev Biol; 2011; 55(4-5):563-7. PubMed ID: 21858777
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiangiogenic therapy for cancer: an update.
    Shojaei F; Ferrara N
    Cancer J; 2007; 13(6):345-8. PubMed ID: 18032969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiangiogenesis therapy. Current and future agents.
    Kieran MW; Billett A
    Hematol Oncol Clin North Am; 2001 Oct; 15(5):835-51, viii. PubMed ID: 11765376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.